Primary Myelofibrosis Completed Phase Trials for Cefotaxime (DB00493)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00445744Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeTreatment